1. Home
  2. AGEN vs KGEI Comparison

AGEN vs KGEI Comparison

Compare AGEN & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.47

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Logo Kolibri Global Energy Inc.

KGEI

Kolibri Global Energy Inc.

HOLD

Current Price

$5.88

Market Cap

139.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
KGEI
Founded
1994
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.4M
139.3M
IPO Year
1999
2009

Fundamental Metrics

Financial Performance
Metric
AGEN
KGEI
Price
$3.47
$5.88
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$14.50
N/A
AVG Volume (30 Days)
889.8K
220.5K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
N/A
EPS
1.02
N/A
Revenue
$42,877,086.00
N/A
Revenue This Year
$107.63
$32.37
Revenue Next Year
N/A
$4.72
P/E Ratio
$3.48
$7.94
Revenue Growth
89.95
N/A
52 Week Low
$2.71
$3.35
52 Week High
$7.34
$8.27

Technical Indicators

Market Signals
Indicator
AGEN
KGEI
Relative Strength Index (RSI) 42.93 61.75
Support Level $2.91 $5.13
Resistance Level $4.72 $6.23
Average True Range (ATR) 0.25 0.26
MACD -0.07 -0.01
Stochastic Oscillator 24.30 97.75

Price Performance

Historical Comparison
AGEN
KGEI

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

About KGEI Kolibri Global Energy Inc.

Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.

Share on Social Networks: